PROQR THERAPEUTICS
ProQR Therapeutics is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa. The company's main product candidates are QR-010, QR-110, and QR-313. Its product pipeline includes QRX-704, QRX-504, QRX-421, QRX-323 etc.
PROQR THERAPEUTICS
Social Links:
Industry:
Biotechnology Genetics Health Care Therapeutics
Founded:
2012-01-01
Address:
Leiden, Zuid-Holland, The Netherlands
Country:
The Netherlands
Website Url:
http://www.proqr.com
Total Employee:
101+
Status:
Active
Contact:
0031-0854894932
Email Addresses:
[email protected]
Total Funding:
359.37 M USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Domain Not Resolving Euro Apple Mobile Web Clips Icon Google Font API Google Maps Mobile Non Scaleable Content Common Name Invalid ASP.NET
Similar Organizations
Cytoguide
Cytoguide is a biotech company that focuses on the development of combined drugs to treat monocyte- and macrophage-related diseases.
De Western Therapeutics Institute
De Western Therapeutics Institute is a biotechnology company that focuses on development of innovative new drags to serve patients worldwide
Medilink Therapeutics
Medilink Therapeutics is a biotech company focusing on next-generation antibody-drug conjugate Research & development.
Pathios Therapeutics
Pathios Therapeutics is a biotech company focused on the development of therapies for autoimmune diseases and cancer.
Regulus Therapeutics
Regulus Therapeutics is a clinical stage biopharmaceutical company focused on the development and discovery of microRNA therapeutics.
Ribon Therapeutics
Ribon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.
Tramontane Therapeutics
Tramontane Therapeutics is a gene therapy company creates solutions for common neurological and metabolic illnesses.
UMR 1283-8199
UMR 1283-8199 is a research laboratory that researches type 2 diabetes and related disorders.
Current Employees Featured
Founder
Stock Details
Investors List
Rett Syndrome Research Trust
Rett Syndrome Research Trust investment in Grant - ProQR Therapeutics
Eli Lilly
Eli Lilly investment in Post-IPO Equity - ProQR Therapeutics
Pontifax
Pontifax investment in Post-IPO Debt - ProQR Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Series A - ProQR Therapeutics
Sofinnova Partners
Sofinnova Partners investment in Seed Round - ProQR Therapeutics
Official Site Inspections
http://www.proqr.com Semrush global rank: 2.73 M Semrush visits lastest month: 6.4 K
- Host name: 136-144-162-130.colo.transip.net
- IP address: 136.144.162.130
- Location: Eindhoven Netherlands
- Latitude: 51.4513
- Longitude: 5.4009
- Timezone: Europe/Amsterdam
- Postal: 5657
More informations about "ProQR Therapeutics"
About ProQR Therapeutics – Patient-focused drug …
About ProQR Therapeutics We are ProQR We are ProQR, a biotechnology company dedicated to changing lives by developing RNA therapies for severe rare and common diseases. We focus on advancing our proprietary …See details»
ProQR - Wikipedia
ProQR Therapeutics NV (NASDAQ: PRQR) is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded in 2012 by chief executive officer (CEO) Daniel A. de Boer. It specializes in the development of RNA therapeutics using its RNA editing platform technology called Axiomer. See details»
ProQR Therapeutics - LinkedIn
ProQR Therapeutics | 15,901 followers on LinkedIn. Advancing our proprietary Axiomer™ RNA-editing platform technology | Changing lives is what drives us at ProQR Therapeutics. We are advancing ...See details»
ProQR Therapeutics - Crunchbase Company Profile
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.See details»
ProQR Therapeutics (PRQR) Company Profile & Description
Jul 16, 2025 Company profile for ProQR Therapeutics N.V. (PRQR) stock, with a description, list of executives, contact details and other key facts.See details»
ProQR - businessabc.net
Apr 10, 2025 ProQR was founded in 2012 by chief executive officer Daniel de Boer and co-founders Henri Termeer, Dinko Valerio and Gerard Platenburg.The initial pipeline of the …See details»
ProQR Therapeutics NV Company Profile - Overview - GlobalData
ProQR Therapeutics NV: Overview ProQR Therapeutics NV (ProQR) is a biotechnology company that primarily focuses on the research and development of RNA therapies for severe rare and …See details»
ProQR Therapeutics BV - bcfcareer.nl
Company activities: ProQR Therapeutics is a clinical-stage biotech company listed on NASDAQ with offices in Leiden, the Netherlands and Cambridge, Massachusetts, US. ProQR is focused …See details»
ProQR Therapeutics — Sofinnova Partners
ProQR Therapeutics [PRQR], based in Leiden, is a biotechnology company dedicated to changing lives by developing RNA therapies for rare genetic diseases. The company focuses drug …See details»
ProQR leadership – An experienced team of healthcare …
ProQR's leadership is a strong team with proven track record. Find out who is on our management team, board of directors and scientific advisory board.See details»
ProQR Therapeutics N.V. (PRQR) - Yahoo Finance
See the company profile for ProQR Therapeutics N.V. (PRQR) including business summary, industry/sector information, number of employees, business summary, corporate governance, …See details»
PROQR THERAPEUTICS N.V. - MarketScreener.com
Feb 20, 2012 ProQR Therapeutics N.V. is a pre-clinical stage biopharmaceutical company based in the Netherlands. The Company is engaged in the discovery and development of …See details»
ProQR Therapeutics - LinkedIn
ProQR Therapeutics | 15,608 followers on LinkedIn. Advancing our proprietary Axiomer™ RNA-editing platform technology | Changing lives is what drives us at ProQR Therapeutics. We are …See details»
ProQR Therapeutics Company Overview, Contact Details
Dec 11, 2024 Learn more about ProQR Therapeutics's company details, contact information, competitors, and more. Find accurate contact data easily with LeadIQ. Book a demo today.See details»
ProQR Therapeutics – Founded on a personal mission to help …
ProQR was founded in 2012 by our current CEO, Daniel A. de Boer. A few years earlier Daniel and his family were faced with the diagnosis of cystic fibrosis in his newborn son, an incurable …See details»
PRQR - Proqr Therapeuti Latest Stock News & Market Updates
Its operational excellence is further demonstrated by the strategic organization of its research programs and active pursuit of regulatory milestones. ProQR’s detailed scientific evaluation …See details»
ProQR - Wikiwand
ProQR Therapeutics NV is a Dutch biotechnology company based in Leiden, the Netherlands, with a presence in Cambridge, Massachusetts, US. The company was funded...See details»
Proqr Therapeutics - Company Profile & Verified Contacts
Discover Proqr Therapeutics's contact details, including key employees’ emails and phone numbers. Explore company insights and data through Leadmap's company directory.See details»
ProQR Therapeutics Annual Report 2021
ProQR Therapeutics N.V., or “ProQR” or the “Company”, is dedicated to changing lives through the creation of transformative RNA therapies for the treatment of severe genetic rare diseases …See details»
Science | ProQR Therapeutics
At ProQR science is literally at the heart of what we do. Our passion lies in discovering the latest RNA technologies and translating them to life-changing treatments.See details»